Blair William & CO Clovis Oncology, Inc. Transaction History

Blair William & CO

  • $33.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$4.06 - $5.8 $409,856 - $585,510
-100,950 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$5.02 - $7.05 $250,999 - $352,500
-50,000 Reduced 33.12%
100,950 $586,000
Q1 2021

May 13, 2021
BUY
$4.81 - $10.34 $726,069 - $1.56 Million
150,950 New
150,950 $1.06 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email